CervoMed Inc. Disposal Group, Including Discontinued Operation, Operating Expense
CervoMed Inc. (CRVO) reported Disposal Group, Including Discontinued Operation, Operating Expense of $192.46 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-04-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense · last filed 2015-04-03
- CervoMed Inc. disposal group, including discontinued operation, operating expense for the quarter ending 2013-12-31 was $19.29K.
- CervoMed Inc. disposal group, including discontinued operation, operating expense for the quarter ending 2013-09-30 was -$110.94K.
- CervoMed Inc. disposal group, including discontinued operation, operating expense for the quarter ending 2013-06-30 was $110.74K.
- CervoMed Inc. disposal group, including discontinued operation, operating expense for the quarter ending 2013-03-31 was $171.89K.
- CervoMed Inc. disposal group, including discontinued operation, operating expense for fiscal 2013 was $192.46K.
| Period end | Disposal Group, Including Discontinued Operation, Operating Expense 3 month | Disposal Group, Including Discontinued Operation, Operating Expense 6 month | Disposal Group, Including Discontinued Operation, Operating Expense 9 month | Disposal Group, Including Discontinued Operation, Operating Expense 12 month |
|---|---|---|---|---|
| 2013-12-31 | $19.29K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | -$91.65K derived: sum of 2 quarters · filed 2015-04-03 | $19.10K derived: sum of 3 quarters · filed 2015-04-03 | $192.46K 10-K · filed 2015-04-03 |
| 2013-09-30 | -$110.94K 10-Q · filed 2014-11-12 | -$194.00 derived: sum of 2 quarters · filed 2014-11-12 | $173.17K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $110.74K 10-Q · filed 2014-08-14 | $284.11K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $171.89K 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |